Literature DB >> 14695235

A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha.

Amanda Blasius1, William Vermi, Anne Krug, Fabio Facchetti, Marina Cella, Marco Colonna.   

Abstract

Natural interferon (IFN)-producing cells (IPCs) recognize certain viruses and DNA containing deoxycytidylate-phosphatedeoxyguanylate (CpG) motifs through the toll-like receptor (TLR) 9, resulting in secretion of IFN-alpha, interleukin 12 (IL-12), and proinflammatory chemokines. Human IPCs are found mainly in inflamed lymph nodes, where they are presumably recruited from the blood to activate both innate and adaptive responses to microbial infections. Demonstrating IPC recruitment and function in murine infection models has been difficult because multiple antibodies are required to distinguish IPCs from other immune cells and very few IPCs can be recovered from lymph nodes. Here we describe a monoclonal antibody (mAb) that exclusively detects murine IPCs in all lymphoid organs under both normal and inflammatory conditions. Using this antibody, we demonstrate that IPCs are normally present in the T-cell zone of lymph nodes and spleen and that inoculation of peripheral tissues with inflammatory stimuli triggers recruitment of IPC into sentinel lymph nodes, whether the stimuli are able to directly stimulate IPCs through TLR or not. Remarkably, we show that incubation of IPCs with the antibody in vitro or administration of the antibody in vivo dramatically reduce secretion of IFN-alpha in response to CpG DNA without causing IPC depletion. Thus, the antibody identifies an IPC-specific surface molecule that, when engaged, inhibits IFN-alpha secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695235     DOI: 10.1182/blood-2003-09-3108

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues.

Authors:  Keely G McDonald; Jacquelyn S McDonough; Brian K Dieckgraefe; Rodney D Newberry
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

2.  TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells.

Authors:  Hiroaki Ito; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2011-12-12       Impact factor: 5.532

Review 3.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

Review 4.  Plasmacytoid dendritic cells: in search of their niche in immune responses.

Authors:  Winfried Barchet; Amanda Blasius; Marina Cella; Marco Colonna
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

6.  Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.

Authors:  Amanda L Blasius; Carrie N Arnold; Philippe Georgel; Sophie Rutschmann; Yu Xia; Pei Lin; Charles Ross; Xiaohong Li; Nora G Smart; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

7.  Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.

Authors:  Amanda L Blasius; Marina Cella; Jorge Maldonado; Toshiyuki Takai; Marco Colonna
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

Review 8.  The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

Authors:  Jessica A Hamerman; Minjian Ni; Justin R Killebrew; Ching-Liang Chu; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

9.  PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon.

Authors:  Hiroshi Watarai; Etsuko Sekine; Sayo Inoue; Ryusuke Nakagawa; Tsuneyasu Kaisho; Masaru Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 10.  Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.

Authors:  Jorge Schettini; Pinku Mukherjee
Journal:  Clin Dev Immunol       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.